Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2016 1
2017 2
2018 3
2019 6
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, Charpy C, Copie-Bergman C, Ziol M, Bioulac-Sage P, Couchy G, Blanc JF, Nahon P, Amaddeo G, Ganne-Carrie N, Morcrette G, Chiche L, Duvoux C, Faivre S, Laurent A, Imbeaud S, Rebouissou S, Llovet JM, Seror O, Letouzé E, Zucman-Rossi J. Nault JC, et al. Among authors: hirsch tz. Hepatology. 2020 Jan;71(1):164-182. doi: 10.1002/hep.30811. Epub 2019 Aug 12. Hepatology. 2020. PMID: 31206197
Adeno-associated virus in the liver: natural history and consequences in tumour development.
La Bella T, Imbeaud S, Peneau C, Mami I, Datta S, Bayard Q, Caruso S, Hirsch TZ, Calderaro J, Morcrette G, Guettier C, Paradis V, Amaddeo G, Laurent A, Possenti L, Chiche L, Bioulac-Sage P, Blanc JF, Letouze E, Nault JC, Zucman-Rossi J. La Bella T, et al. Among authors: hirsch tz. Gut. 2020 Apr;69(4):737-747. doi: 10.1136/gutjnl-2019-318281. Epub 2019 Aug 2. Gut. 2020. PMID: 31375600 Free article.
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ, Negulescu A, Gupta B, Caruso S, Noblet B, Couchy G, Bayard Q, Meunier L, Morcrette G, Scoazec JY, Blanc JF, Amaddeo G, Nault JC, Bioulac-Sage P, Ziol M, Beaufrère A, Paradis V, Calderaro J, Imbeaud S, Zucman-Rossi J. Hirsch TZ, et al. J Hepatol. 2020 May;72(5):924-936. doi: 10.1016/j.jhep.2019.12.006. Epub 2019 Dec 18. J Hepatol. 2020. PMID: 31862487 Free article.
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M, Caruso S, Hirsch TZ, Bayard Q, Franconi A, Védie AL, Noblet B, Blanc JF, Amaddeo G, Ganne N, Ziol M, Paradis V, Guettier C, Calderaro J, Morcrette G, Kim Y, MacLeod AR, Nault JC, Rebouissou S, Zucman-Rossi J. Ningarhari M, et al. Among authors: hirsch tz. J Hepatol. 2021 May;74(5):1155-1166. doi: 10.1016/j.jhep.2020.11.052. Epub 2020 Dec 15. J Hepatol. 2021. PMID: 33338512 Free article.
Functions of the Prion Protein.
Hirsch TZ, Martin-Lannerée S, Mouillet-Richard S. Hirsch TZ, et al. Prog Mol Biol Transl Sci. 2017;150:1-34. doi: 10.1016/bs.pmbts.2017.06.001. Epub 2017 Jul 23. Prog Mol Biol Transl Sci. 2017. PMID: 28838656 Review.
APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures.
Morcrette G, Hirsch TZ, Badour E, Pilet J, Caruso S, Calderaro J, Martin Y, Imbeaud S, Letouzé E, Rebouissou S, Branchereau S, Taque S, Chardot C, Guettier C, Scoazec JY, Fabre M, Brugières L, Zucman-Rossi J. Morcrette G, et al. Among authors: hirsch tz. Oncoimmunology. 2019 Mar 28;8(6):e1583547. doi: 10.1080/2162402X.2019.1583547. eCollection 2019. Oncoimmunology. 2019. PMID: 31069152 Free PMC article.
PrP(C) from stem cells to cancer.
Martin-Lannerée S, Hirsch TZ, Hernandez-Rapp J, Halliez S, Vilotte JL, Launay JM, Mouillet-Richard S. Martin-Lannerée S, et al. Among authors: hirsch tz. Front Cell Dev Biol. 2014 Sep 29;2:55. doi: 10.3389/fcell.2014.00055. eCollection 2014. Front Cell Dev Biol. 2014. PMID: 25364760 Free PMC article. Review.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page